ask="2.58"
ask_size="1500"
average_daily_volume="1054800"
bid="2.50"
bid_size="200"
book_value="0.34"
change="-0.20"
change_from_200_day_moving_average="0.84"
change_from_50_day_moving_average="0.55"
change_from_52_week_high="-1.55"
change_From_52_week_low="1.47"
change_in_percent="-7.19%"
close="2.58"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.23"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="0.95"
ex_dividend_date="N/A"
float_shares="4441000"
high="2.81"
high_52_weeks="4.13"
last_trade_date="3/8/2017"
last_trade_price="2.58"
last_trade_size="1021"
last_trade_time="4:00pm"
low="2.54"
low_52_weeks="1.11"
market_capitalization="24.73M"
moving_average_200_day="1.74"
moving_average_50_day="2.03"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.00"
open="2.73"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+48.56%"
percent_change_from_50_day_moving_average="+26.98%"
percent_change_from_52_week_high="-37.53%"
percent_change_from_52_week_low="+132.43%"
previous_close="2.78"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="2.72"
price_per_book="8.20"
price_per_sales="52.36"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="1.02"
stock_exchange="NCM"
symbol="EYEG"
volume="678079"
weeks_range_52="1.11 - 4.13"
